Imatinib Mesylate CAS: 220127-57-1
| Product Parameters | |
|---|---|
| Catalog No. | BA5XQ3 |
| CAS.RN | 220127-57-1 |
| Molecular Formula | C30H35N7O4S |
| Molecular Weight | 589.71 g/mol |
| Purity | NLT 98% |
Product Overview
Imatinib mesylate is a targeted therapy drug primarily used to treat malignant tumors such as chronic myeloid leukemia and gastrointestinal stromal tumors. It is a representative compound of the tyrosine kinase inhibitor class of drugs. As an active pharmaceutical ingredient (API), this product is widely used in pharmaceutical research and development, process development, and commercial production. It is suitable for small-scale, pilot-scale, and industrial-scale production during the research and development phase, exhibiting good stability and reproducibility, and meeting the pharmaceutical industry's demand for high-purity, high-quality APIs.
Applications
- Synthesis of key intermediates in drug development
- Supply of active pharmaceutical ingredients (APIs) for tyrosine kinase inhibitors
- Process optimization and route development in pharmaceutical companies
- Preparation of drugs for the treatment of gastrointestinal stromal tumors
- Commercial production of drugs for the treatment of chronic myeloid leukemia
Quality & Supply Capability
English Name: Imatinib Mesylate Properties: White to off-white crystalline powder, readily soluble in water, with good thermal stability. Its molecular structure contains a methanesulfonic acid group, making it a typical tyrosine kinase inhibitor suitable for various synthetic routes. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific requirements. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized mass production. We can flexibly adjust the supply plan according to the customer's specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical support team to assist customers in process development, route optimization, and project transformation, ensuring a seamless transition from R&D to mass production.
Why Choose Bioncan
Focused on active pharmaceutical ingredients (APIs), with extensive experience in supplying pharmaceutical intermediates and APIs. Full-scale supply capabilities, covering all stages from laboratory to commercial production. Comprehensive quality control documentation support, including COA, MSDS, HPLC, NMR, etc. Customization support available, with adjustments to purity, impurity limits, and packaging to meet client requirements. Comprehensive process optimization and technical support services to help clients successfully scale up projects and achieve industrialization.
Intermediates of Imatinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA24X2 | Imatinib API | 152459-95-5 |
| BK44GE | N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | 152460-10-1 |
| BK4VR3 | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride | 106261-49-8 |
| BA5XQ3 | Imatinib Mesylate | 220127-57-1 |
| BK64T0 | 4-(4-Methylpiperazinylmethyl)benzoyl chloride dihydrochloride | 106261-64-7 |
| BK317V | N-Desmethyl Imatinib | 404844-02-6 |
| BK9H30 | N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine | 152460-09-8 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 220127-57-1, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.
